DAHL ANDREW A 4
4 · Zivo Bioscience, Inc. · Filed Apr 8, 2020
Insider Transaction Report
Form 4
DAHL ANDREW A
President, CEO
Transactions
- Award
Common Stock Purchase Option
2019-11-15+28,000,000→ 28,000,000 totalExercise: $0.10From: 2019-11-15Exp: 2029-11-15→ Common Stock (28,000,000 underlying) - Award
Common Stock Purchase Option
2019-12-06+1,000,000→ 1,000,000 totalExercise: $0.14From: 2019-12-06Exp: 2029-12-06→ Common Stock (1,000,000 underlying)
Footnotes (1)
- [F1]The warrants were issued to the reporting person as compensation for his services as President and CEO.